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ABSTRACT
We investigated whether there is any association between a native-like conformation and the presence of only the canonical (i.e.,
native) disulfide bonds in the gp120 subunits of a soluble recombinant human immunodeficiency virus type 1 (HIV-1) envelope
(Env) glycoprotein. We used a mass spectrometry (MS)-based method to map the disulfide bonds present in nonnative un-
cleaved gp140 proteins and native-like SOSIP.664 trimers based on the BG505 env gene. Our results show that uncleaved gp140
proteins were not homogeneous, in that substantial subpopulations (20 to 80%) contained aberrant disulfide bonds. In contrast,
the gp120 subunits of the native-like SOSIP.664 trimer almost exclusively retained the canonical disulfide bond pattern. We also
observed that the purification method could influence the proportion of an Env protein population that contained aberrant di-
sulfide bonds. We infer that gp140 proteins may always contain a variable but substantial proportion of aberrant disulfide bonds
but that the impact of this problem can be minimized via design and/or purification strategies that yield native-like trimers. The
same factors may also be relevant to the production and purification of monomeric gp120 proteins that are free of aberrant di-
sulfide bonds.
IMPORTANCE
It is widely thought that a successful HIV-1 vaccine will include a recombinant form of the Env protein, a trimer located on the
virion surface. To increase yield and simplify purification, Env proteins are often made in truncated, soluble forms. A conse-
quence, however, can be the loss of the native conformation concomitant with the virion-associated trimer. Moreover, some sol-
uble recombinant Env proteins contain aberrant disulfide bonds that are not expected to be present in the native trimer. To as-
sess whether these observations are linked, to determine the extent of disulfide bond scrambling, and to understand why
scrambling occurs, we determined the disulfide bond profiles of two soluble Env proteins with different designs that are being
assessed as vaccine candidates. We found that uncleaved gp140 forms heterogeneous mixtures in which aberrant disulfide bonds
abound. In contrast, BG505 SOSIP.664 trimers are more homogeneous, native-like entities that contain predominantly the na-
tive disulfide bond profile.
The first human immunodeficiency virus type 1 (HIV-1) vac-cine trial (designated RV144) to yield one statistically signifi-
cant measure of efficacy was reported in 2009 (1). Since then,
attempts to substantially improve on those initial results have
been ongoing. Many vaccine design strategies are focused on the
HIV-1 Env protein, which is the trimeric antigen present on the
viral surface. Some Env immunogens, including proteins used in
the RV144 trial, are based on a soluble monomeric form of the
gp120 subunit of the trimer (1–7). An alternative approach in-
volves soluble oligomeric gp140 proteins that contain both gp120
and the external component of the gp41 subunit (8–13). The con-
cept underlying the use of gp140 proteins is that they may better
mimic the native virion-associated trimer and hence may be su-
perior to the individual gp120 subunits at inducing virus neutral-
izing antibodies (NAbs) (8–10). The underlying assumption is
now known to be invalid in many cases, since the precise design of
the soluble gp140 protein is critical for achieving trimer mimicry
(11–16).
While one can now infer whether or not a gp140 protein adopts
a native-like trimer structure by visualizing it using negative-stain
electron microscopy (NS-EM) (11, 12, 14–16), the factors that
govern the formation of a native Env protein are only now becom-
ing clear. Increased knowledge of why native and nonnative Env
proteins differ, and how those differences arise, may therefore be
of substantial value for the further improvement of all Env-based
immunogens.
Glycosylation is one modification with regard to which native
or native-like Env trimers differ from gp120 monomers or non-
native uncleaved gp140 oligomers: specifically, the native Env
proteins are enriched in high-mannose glycans, while the glycans
on gp120 monomers and nonnative gp140s are more highly pro-
cessed (14, 17–21). However, since glycan processing occurs only
after the Env protein folds and, when relevant, trimerizes, these
differences are likely to be a consequence and not a cause of native
trimer formation. In contrast, the generation of intramolecular
disulfide bonds is one of the earliest steps in Env protein process-
Received 10 October 2015 Accepted 21 December 2015
Accepted manuscript posted online 30 December 2015
Citation Go EP, Cupo A, Ringe R, Pugach P, Moore JP, Desaire H. 2016. Native
conformation and canonical disulfide bond formation are interlinked properties
of HIV-1 Env glycoproteins. J Virol 90:2884 –2894. doi:10.1128/JVI.01953-15.
Editor: G. Silvestri
Address correspondence to Heather Desaire, hdesaire@ku.edu.
Supplemental material for this article may be found at http://dx.doi.org/10.1128
/JVI.01953-15.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
crossmark
2884 jvi.asm.org March 2016 Volume 90 Number 6Journal of Virology
 on D
ecem









ing, starting during mRNA translation and continuing as the nas-
cent protein folds. For most genotypes, the gp120 protein
(whether a monomer or a trimer subunit) contains nine intramo-
lecular disulfide bonds, and there is also one such bond in the gp41
component of gp140 proteins (22–26). The potential for the for-
mation of aberrant disulfide bonds as the gp120 or gp140 proteins
fold and assemble is obvious. Here we have assessed the relation-
ship between the disulfide bond profiles of two soluble Env pro-
teins and their adoption of a native-like structure. Our primary
goal was to better understand the interplay between disulfide ex-
change, protein folding, and glycosylation modifications during
the formation of Env trimers.
The canonical disulfide-bonding pattern present in mono-
meric gp120 was first reported in 1990 (25). The same pattern has
since been seen in all high-resolution structures of NAb complexes
of gp120 monomers or native-like trimers, including NAbs that
recognize trimer-specific epitopes (10, 27–30). The structural data
strongly imply that the canonical pattern is the one associated with
native, trimeric Env, but the structures do not address whether
other Env proteoforms can also be present. Thus, a nonnative
form of Env with a different disulfide bond profile probably would
not bind the cocrystallizing antibody and hence would be ex-
cluded from the crystal.
Noncanonical (i.e., aberrant) disulfide bonds can indeed be
present in HIV-1 Env proteins. The formation of aberrant inter-
molecular disulfide bonds causes the cross-linking of Env proteins
into dimers and aggregates (31, 32). There are also multiple re-
ports of recombinant gp120 and gp140 proteins that contain ab-
errant intramolecular disulfide bonds (6, 15, 23, 24, 33). We show
here that the gp120 subunits of native-like BG505 SOSIP.664
trimers contain predominantly the canonical disulfide-bonding
profile. In contrast, a nonnative, uncleaved gp140 protein of the
same BG505 genotype contains substantial amounts of all the ab-
errant disulfide bonds that were previously reported to be present
in Env proteins of comparable designs (6, 15, 23, 33). The aberrant
disulfide bonds were also present in SOSIP.664 gp140 monomers
and dimers, implying that the SOSIP trimer-stabilizing modifica-
tions do not prevent this problem per se. Instead, we propose that
the engineered SOSIP stabilization changes facilitate the produc-
tion of native-like trimers from which aberrantly folded gp120
subunits are excluded. Taking into account recent knowledge of
the glycosylation profiles of native trimers and nonnative Env pro-
teins (11, 14, 19–21), we postulate that the disulfide-bonding pro-
file determines the potential of a proteoform to pack into a native
trimer and that stabilizing modifications such as the SOSIP
changes then prevent disulfide exchange reactions within the as-
sembled trimer. Thus, there is an inherent interrelationship be-
tween native disulfide bonding, native structure, and native gly-
cosylation profile.
Our observations also have practical relevance to vaccine de-
sign, by guiding the production and purification of Env proteins
with a native disulfide bond profile. Such proteins, be they gp120
monomers or gp140 trimers, may prove to be better immunogens
for NAb induction than counterparts containing contaminants in
which substantial amounts of aberrant disulfide bonds have
formed.
MATERIALS AND METHODS
Reagents. Trizma base, citric acid, high-performance liquid chromatogra-
phy (HPLC)-grade acetonitrile (CH3CN), Optima methanol (CH3OH),
4-vinylpyridine, glacial acetic acid, and Optima LC–MS-grade formic acid
were purchased from Sigma (St. Louis, MO) and Fisher Scientific (Pittsburgh,
PA). Water was purified using a Millipore (Billerica, MA) Direct-Q3 water
purification system. Sequencing-grade trypsin was obtained from Promega
(Madison, WI). Glycerol-free peptidyl-N-glycosidase F (PNGase F), cloned
from Flavobacterium meningosepticum, was bought from New England
BioLabs (Ipswich, MA).
Expression and purification of Env proteins. The BG505 SOSIP.664
and WT.SEKS constructs have been described previously (16, 34). The
SOSIP.664 trimers were produced in a stable CHO cell line (35), while the
WT.SEKS proteins were made by transient transfection of 293T cells (16).
In both cases, the Env proteins were initially isolated via a 2G12 broadly
neutralizing antibody (bNAb)-affinity column, followed by size exclusion
chromatography (SEC) to isolate the trimer fractions, as described previ-
ously (14, 16, 34). The BG505 SOSIP.664-His native-like trimers, which
contain a C-terminal His tag, were purified by Ni-nitrilotriacetic acid
(NTA) affinity chromatography followed by SEC (14, 15). In some stud-
ies, SEC column fractions containing BG505 SOSIP.664 or SOSIP.664-
His gp120 – gp41 monomers and dimers were also collected (36). As
viewed by negative-stain EM, the BG505 SOSIP.664 trimers are native-
like, regularly shaped trilobed structures, whereas the uncleaved
WT.SEKS gp140 proteins adopt irregular, splayed-out shapes (16, 34).
Deglycosylation of BG505 Env proteins. Samples containing 50 g
of Env were alkylated with a 10-fold molar excess of 4-vinylpyridine for 1
h at room temperature in the dark in order to cap free cysteine residues
prior to deglycosylation and thereby prevent disulfide bond shuffling.
Deglycosylation was performed by incubating Env samples with 1 l of a
PNGase F solution (500,000 U/ml) in 50 mM Tris citrate buffer (pH 6.5)
for 1 week at 37°C, as described previously (24).
Proteolytic digestion of BG505 Env proteins. The fully deglycosy-
lated and alkylated samples (see above) were digested overnight with tryp-
sin (protein-to-enzyme ratio, 30:1) at 37°C (23, 24). To generate consis-
tent and reproducible Env digests, the complete deglycosylation and
subsequent proteolytic digestion procedures were performed at least
twice on different days, using samples obtained from the same Env ex-
pression batches. Each of these samples was subjected to liquid chroma-
tography (LC)-mass spectrometry (MS) analysis, as described below, and
at least two replicate experimental runs were performed on each digest.
Thus, in total, four replicate data files were generated for each protein.
Chromatography and mass spectrometry. High-resolution LC–tan-
dem MS (MS-MS) experiments were performed using an Orbitrap Velos
Pro hybrid mass spectrometer (Thermo Scientific, San Jose, CA) coupled
to an Acquity ultra-performance liquid chromatography (UPLC) system
(Waters, Milford, MA). Chromatography was performed using mobile
phases consisting of solvent A (99.9% deionized H2O plus 0.1% formic
acid) and solvent B (99.9% CH3CN plus 0.1% formic acid) with a gradient
of 3% to 40% solvent B in 50 min. The column was held at 97% solvent B
for 10 min before reequilibration. Five microliters of the sample (4 to 5
M) was injected onto a PepMap 300 C18 column (inside diameter [i.d.],
300 m; length, 15 cm; pore size, 300 Å; Thermo Scientific, Sunnyvale,
CA) at a flow rate of 5 l/min. A short wash and a blank run were per-
formed between every two samples to ensure that there was no sample
carryover. All mass spectrometric analysis was performed in a data-de-
pendent mode as described below. The Orbitrap Velos Pro hybrid mass
spectrometer was set up to perform experiments by alternating collision-
induced dissociation (CID) and electron transfer dissociation (ETD) ac-
quisition. Data-dependent acquisition (DDA) was set up to acquire 10
scan events: for every full high-resolution MS scan in the mass range from
400 to 2,000 m/z, each selected m/z in the MS scan was subjected to three
MS-MS events in the ion trap: (i) CID, (ii) ETD, and (iii) CID of the
charge-reduced precursor in the previous ETD event. The mass spectro-
metric parameters used for the experiment were as follows: spray voltage,
3.0 kV; S-lens value, between 45 and 55%; capillary temperature, 250°C;
normalized collision energy, 35% for CID. The ion-ion reaction for ETD
between the precursor ion and the radical anion, fluoranthene, was set at
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an automatic gain control (AGC) target value of 2  105 and a 100-ms
ion-ion reaction time. To improve ETD efficiency, supplemental activa-
tion was turned on. The Orbitrap Velos Pro hybrid mass spectrometer was
set at a resolution (R) of 30,000 at m/z 400. Under these conditions, the
measured R (full width at half maximum [FWHM]) is 22,000 at m/z 1,000
and 16,000 at m/z 1,500.
Peptide identification. Peptides containing free cysteine residues
were identified by searching raw data against a custom HIV database
including 157 gp120/gp41 sequences, obtained from the Los Alamos HIV
Sequence Database (http://www.hiv.lanl.gov/content/sequence
/HIV/mainpage.html), using Mascot (Matrix Science, London, United
Kingdom, version 2.5). The peak list was extracted from raw files by use of
the MassMatrix conversion tool. Mascot generic format (mgf) files were
searched by specifying the following parameters: (i) enzyme, trypsin; (ii)
missed cleavages, up to 2; (iii) fixed modification, pyridylethylation; (iv)
variable modifications, methionine oxidation and pyro-Glu (Q at N ter-
minus); (v) peptide tolerance, 0.5 Da; (vi) MS-MS tolerance, 0.3 Da. Pep-
tides identified from the Mascot search with 95% confidence were man-
ually validated from tandem mass spectrometry (MS-MS) data to ensure
that major fragmentation ions (b, c, y, and z ions) were observed, espe-
cially for peptides generated from PNGase F-treated samples that con-
tained Asn-to-Asp conversions.
Disulfide bond analysis. Raw data acquired from the experiments
were analyzed manually. To facilitate the analysis, peptides containing
S-pyridylethyl-labeled cysteine residues were first identified using the
Mascot search engine as described above. Once the free cysteine residues
were identified, the analysis involved using a prediction table containing
the sum of the masses of all possible HIV-1 Env disulfide-linked peptide
pairs minus 2 Da, at different charge states. From the calculated m/z ratios
of the plausible candidates, the elution time profile (or extracted ion chro-
matogram [XIC]) was constructed. For each plausible candidate, the MS
data and corresponding CID and/or ETD spectra of the targeted disulfide-
linked peptide that were needed for identification were extracted from the
constructed XIC. The observed peptide fragment ions from CID (b/y
ions) and ETD (c/z ions) data for each ion identified in the MS scan were
manually matched to the theoretical peptide fragment ions generated us-
ing MS-Product from ProteinProspector (http://prospector.ucsf.edu
/prospector/mshome.htm). Matched fragment ions that were within 0.5
Da of the theoretical value were accepted. In addition to the characteristic
c and z fragment ions observed in ETD, ions corresponding to the peptide
fragments resulting from cleavage of the disulfide bond during ETD were
required to be present in the ETD spectra for the assignment to be
unambiguous.
RESULTS
The disulfide bond profiles of the BG505 uncleaved WT.SEKS and
cleaved SOSIP.664 trimers were ascertained using MS-based
methods for protein disulfide bond determination that have been
described previously (6, 23, 24, 33). In brief, the proteins were
deglycosylated with PNGase F and were digested with trypsin un-
der acidic conditions that preserve disulfide bonds intact. The
disulfide-linked peptides derived were analyzed by liquid chroma-
tography–tandem mass spectrometry (LC–MS-MS) methods. A
typical example is shown in Fig. 1A. High-resolution MS data for
the portion of the chromatogram containing the first disulfide-
bonded peptide in BG505 Env are shown in Fig. 1B. This disulfide-
bonded peptide, comprising DAETTLFC54ASDAK and HNVWA
THAC74VPTDPNPQEIHLEDVTEEFNMWK, which are linked
via the Cys residues at positions 54 and 74 (shown in boldface),
has a theoretical m/z of 1,032.0687 in the 5 charge state and is
detected within a 6-ppm mass error in the mass spectrum (Fig.
1B). In addition to the 5 charge state, the same disulfide-linked
peptide is also readily detected in numerous other charge states
(Fig. 1B). Its identity is further confirmed by MS-MS experiments;
the ETD data used to support this particular assignment are
shown in Fig. 1C, where numerous c and z ions consistent with the
disulfide-linked peptide can be seen as abundant peaks in the
spectrum. Each disulfide-linked peptide that we describe in Tables
1, 2, and 3 was verified using the same approach. Specifically, first,
the high-resolution MS data, within a mass error of 10 ppm, were
detected for each species, and then the assignment was confirmed
by the MS-MS data. All of the canonical disulfide-bonded pep-
tides and all feasible aberrant disulfide-bonded peptides were
searched for individually in each data set, as described previously
(24, 33). The canonical and aberrant disulfide-bonded peptides
detected for each BG505 protein are described in Tables 1 and 2,
respectively.
For both the BG505 WT.SEKS and SOSIP.664 trimers, all the
canonical disulfide bonds were detected (Table 1). These findings
are consistent with all our previous disulfide-bonding analyses of
gp140 proteins, since the canonical form is always present to some
extent (6, 15, 23, 24, 33). A notable new observation, however, is
summarized in Table 2. There it is shown that the trimer fraction
of the uncleaved BG505 WT.SEKS gp140 preparation contains
proteins with numerous aberrant disulfide bonds in gp120 do-
mains I, II, and III. However, in marked contrast, all of these
aberrant forms are almost completely absent from the corre-
sponding SOSIP.664 trimers. Of note is the fact that the compar-
ator proteins were both purified by the same strategy of 2G12
bNAb affinity chromatography followed by SEC to isolate the
trimer fraction, so the differences between these proteins are not
rooted in the purification process.
We assessed whether the substantial differences between these
BG505 WT.SEKS and SOSIP.664 proteins arose because they had
been expressed in two different cell lines (293T and CHO cells,
respectively). For this purpose, we expressed the SOSIP.664 trim-
ers by transiently transfecting 293T cells, followed by 2G12/SEC
purification, and determined their disulfide bond profile. The re-
sulting disulfide-bonded peptides were identical to those found
for the BG505 SOSIP.664 trimers expressed in CHO cells and
purified by 2G12/SEC (data not shown). The different disulfide
bond contents of the SOSIP.664 and WT.SEKS proteins are there-
fore not attributable to the producer cell.
To better assess the magnitude of the differences between the
two types of Env protein, we estimated the sizes of the subpopu-
lations that contained the aberrant forms. To do so, we studied the
MS data associated with the aberrant disulfide-bonded peptides in
greater detail. The MS data for one of the aberrant disulfide-
bonded peptides in the V1/V2 region (m/z 788) are shown in Fig.
2, together with a coeluting tryptic peptide (LDVVQINENQGNR;
m/z 750) from the protein sequence, which serves as an internal
standard (see below). The extracted ion chromatograms of the
peptides from the WT.SEKS protein and the corresponding mass
spectrum are shown in Fig. 2A and B, respectively. The aberrant
disulfide-bonded peptide, m/z 788, is readily detectable in both
plots for the WT.SEKS protein, but it is barely detectable above the
baseline in the corresponding data plots for the SOSIP.664 trimer
(Fig. 2C and D).
A simple visual inspection of the data sets presented above
suggests that the aberrant peptide is substantially less abundant in
the SOSIP.664 trimer than in its uncleaved, nonnative WT.SEKS
counterpart. To provide a more quantitative estimate of the dif-
ference, we used the intensity of the coeluting peptide, m/z 750, as
an internal standard. The use of coeluting compounds as internal
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standards to achieve quantitative results is a well-established mass
spectrometry technique (37–39). This approach enabled us to es-
timate that the aberrant disulfide-bonded peptide is 20-fold less
prevalent in the SOSIP.664 trimer preparation than in the un-
cleaved WT.SEKS gp140. (In three replicate injections, the esti-
mates of the difference ranged from 17- to 23-fold, with a mean
value of 20-fold). While these analyses provide quantitative infor-
mation on a relative scale, not an absolute scale, it is clear that the
prevalence of aberrantly formed disulfide bonds is far greater
(20-fold) in the uncleaved gp140 protein than in the native-like
SOSIP.664 trimer. To put the difference into perspective, it is
relevant that we estimate that the biochemical purity of the
FIG 1 MS data for tryptic digest of BG505 Env proteins. (A) Base peak chromatogram of the protein digest. (B) High-resolution mass spectrum for a portion of
the chromatogram, highlighted in panel A. Several charge states are detected for the disulfide-linked peptide. (C) ETD spectrum of the disulfide-linked peptide
detected in panel B.
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SOSIP.664 trimers is likely to be in the range of 96 to 99%.
Thus, when 2G12/SEC-purified BG505 SOSIP.664 trimers are
analyzed on blue native gels, contaminant monomers and
dimers typically are not detectable (34). Accordingly, our min-
imum estimate of trimer purity is 96%. It is reasonable to
suggest that at least some dimers and aggregates will still be
present even after SEC purification, since 100% size homoge-
neity is unlikely to be achievable by this method alone. Addi-
tional information on the purity of trimers after SEC is pro-
vided in Fig. S1 in the supplemental material.
The fact that the protein fraction used for these studies is 96
to 99% trimers is relevant because we show below that nontri-
meric BG505 SOSIP.664 proteins (i.e., monomers and dimers)
are enriched for aberrant disulfide bonds relative to trimers.
Thus, if the frequency of the disulfide scrambled V2 domain is
in the range of 1 to 4% for the overall SOSIP.664 trimer
preparation as a result of a low level of nontrimer contami-
nants, the 20-fold-greater prevalence of the aberrant V2 do-
main in uncleaved WT.SEKS trimer populations implies that
20 to 80% of these Env proteins are misfolded in this way.
Irrespective of the exact proportion of the uncleaved gp140
proteins that is aberrantly disulfide bonded, it is clear that the
percentage of the total population that is affected is not small
but substantial, possibly even the majority. The implications
for vaccine design are therefore substantive.
The only other aberrant disulfide-linked peptide that was de-
tectable in both the WT.SEKS and SOSIP.664 trimer preparations
was from the gp120 C2 region (Table 2). In both cases, we estimate
that this scrambled peptide is present at a low abundance, since
the signals for these peaks are about 100-fold lower than those
TABLE 1 Canonical disulfide bonds in BG505SOSIP.664 and WT.SEKS trimers
a
a CS, charge state.
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for many other peptides. However, based on the peak intensities
relative to those of other, coeluting species, the scrambled C2 pep-
tide was, again, less prevalent in the SOSIP.664 trimer than in the
WT.SEKS gp140. Several other aberrant disulfide bonds in the C1,
C2, and C3 regions were detectable only in the WT.SEKS proteins
(Table 2).
We next addressed whether all secreted Env proteins contain-
ing the SOSIP.664 modifications behave in the same way with
respect to their disulfide bond content. To do so, we purified His-
tagged BG505 SOSIP.664 Env proteins either by 2G12 affinity
chromatography, as before, or by Ni2-NTA affinity chromatog-
raphy (14, 15). In both cases, we then isolated the gp140 mono-
mer, dimer, and trimer fractions eluting from the SEC column
and determined their disulfide bond profiles. An example of an
SEC profile showing the pooled fractions can be found in Fig. S2 in
the supplemental material, and the results of the disulfide analysis
are shown in Table 3. The canonical disulfide bonds were always
detected in each protein (not shown) and were accompanied by
various numbers of aberrant disulfide-bonded peptides. Of great-
est relevance is the fact that the SOSIP.664 gp140 monomers and
dimers contained considerably more of the nonnative disulfide
bonds than the trimers, irrespective of whether the Env proteins
were purified on the 2G12 or the Ni-NTA-column prior to SEC
(Table 3).
DISCUSSION
Here we have confirmed and extended earlier reports that HIV-1
Env proteins can contain noncanonical (i.e., aberrant) disulfide
bonds (6, 15, 23, 24, 33). The nine disulfide bonds present in the
monomeric HIV-1 IIIB gp120 protein were first identified in 1990
(25) and have since been seen in high-resolution structures of
native-like trimers (27–30). However, various gp120 and un-
cleaved gp140 proteins contain subpopulations in which the ca-
nonical disulfide bonds have not formed, and alternative config-
urations are present instead (6, 15, 23, 24, 33). The aberrant
disulfide bonds are most prevalent in, but not limited to, the N-
terminal half of the protein, and particularly the V1/V2 loop re-
gion. The consequence of forming aberrant disulfide bonds is that
the resulting subset of gp120 monomers or gp140 subunits is mis-
folded. In addition, intermolecular disulfide bonds can also form,
creating gp120 dimers (31, 32). For the uncleaved gp140 proteins,
the problems created by aberrant disulfide bond formation are
TABLE 2 Aberrant disulfide bonds in BG505 SOSIP.664 and WT.SEKS trimers
a
a CS, charge state.
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exacerbated by the formation of dimerizing/aggregating cross-
links between different molecules (23, 24, 35). In addition, aber-
rant cross-links probably also arise between the gp120 subunits
within a single gp140 protein, further exacerbating the heteroge-
neity and nonnative conformation of these entities.
A limitation to the earlier studies of gp120 and uncleaved
gp140 proteins is that it was not possible to quantify the propor-
tion of gp120 subunits that were affected by disulfide bond scram-
bling (6, 23, 24, 33). Thus, whether the problem affected, for ex-
ample, 1% or 50% of the gp120 moieties was unknown but of
major significance to the potential use of these proteins as vaccine
immunogens. Now, by conducting comparative studies with na-
tive-like SOSIP.664 trimers that we show to be only minimally
affected by disulfide bond scrambling, we find that aberrant disul-
fide bonds are present in a substantial proportion of nonnative
gp140 proteins (possibly as high as 40 to 80% for BG505
WT.SEKS). Taking this finding together with a similar outcome of
a study based on 92UG037.8 and CZA97.012 Env proteins (15),
we can conclude that gp120 monomers and uncleaved gp140 pro-
teins commonly contain a substantial number of noncanonical
disulfide bonds (15). Viewing of the uncleaved gp140 proteins by
EM and analysis by other biophysical techniques show that this
problem contributes to their nonnative configurations (11, 12,
14–16, 20). The implications for the effectiveness of Env proteins
with these designs as vaccine components now merit careful con-
sideration. We note that the BG505 WT.SEKS protein was very
poorly immunogenic in rabbits, both in absolute terms and rela-
tive to the native-like BG505 SOSIP.664 trimers (40).
What underlies the formation of aberrant disulfide bonds in
Env proteins? Uncertainties remain, some of which could be ex-
plored in future studies on other forms of Env purified in various
ways. It is possible that the formation of aberrant disulfide bonds
in recombinant forms of Env reflects their overexpression, relative
to viral Env expression, in transfection systems. We note, how-
ever, that this would not account for the difference between na-
tive-like trimers and nonnative gp140 proteins, since in our gen-
eral experience, total Env expression is comparable in both cases
(typically 2 to 5 mg/liter). An alternative possibility is that disul-
fide heterogeneity is also present in viral Env as part of an immune
evasion strategy that involves creating nonnative forms of Env to
induce irrelevant, distractive antibodies. Thus, it has long been
known that the population of full-length Env proteins present on
the surfaces of virus-infected or Env-transfected cells is highly
heterogeneous, with both native and nonnative forms readily de-
tectable (41–45). We hypothesize that the nonnative forms of Env
will be enriched for gp120 subunits containing aberrant disulfide
bonds. The same scenario might also apply in the vaccine context;
thus, nonnative, disulfide-scrambled Env protein subpopulations
may, at least to some extent, distract the immune response away
from any better-folded, more native-like proteins that are also
present.
The disulfide heterogeneity problem is common to recombi-
nant soluble Env proteins of multiple designs (6, 15, 23, 24, 33).
Thus, it affects SOSIP.664 gp140 monomers and dimers as well as
gp120 monomers and uncleaved gp140 proteins that contain or
lack Foldon-trimerization domains (15). In each case, we propose
that the initially expressed gp120 moieties include subpopulations
containing both canonical and aberrant disulfide bonds. We also
propose that any gp120 subunits containing aberrant disulfide
bonds will be excluded from native-like trimers, because they can-
not pack properly against one another in the trimer context. We
further propose that once the compact, native-like trimers form,
FIG 2 MS data for an aberrant disulfide-linked peptide. (A) Extracted ion chromatograms for the aberrant peptide, at m/z 788, and a coeluting peptide, m/z 750,
from the digest of BG505 WT.SEKS gp140. (B) Mass spectrum for the peak shown in panel A. (C) Extracted ion chromatograms for the aberrant peptide, at m/z
788, and a coeluting peptide, m/z 750, from the digest of BG505 SOSIP.664. (D) Mass spectrum for the peak shown in panel C.
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their gp120 subunits are inaccessible to protein disulfide isomer-
ase (PDI), the enzyme in the endoplasmic reticulum (ER) that
allows proteins to sample many different disulfide-bonding pro-
files. In contrast, gp120 monomers and nonnative gp140 proteins
that are not subject to the steric constraints imposed by trimeriza-
tion probably do remain exposed to PDI and thus continue to
undergo disulfide exchange until they exit the ER (Fig. 3). The
argument here is analogous to that used to account for the higher
oligomannose content of native-like trimers than of gp120 and
uncleaved gp140 proteins: i.e., steric constraints restrict the access
of mannosidase to its glycan substrates on the trimer but not on
the other Env forms (14, 15, 19, 20). Thus, in the absence of steric
constraints, the glycans on the gp120 subunits of nonnative gp140
proteins can be processed further to complex glycoforms that dif-
fer from those found on native, trimeric Env (14, 15, 19–21).
NS-EM imaging shows how the compact native-like SOSIP.664
trimers differ from the splayed-out, nonnative gp140 proteins, differ-
ences reinforced by proteolysis and hydrogen/deuterium exchange
studies that directly address the relative accessibility of the protein
surfaces to enzymes and solvent (13, 15, 16, 20). The outcomes of
these in vitro analyses are entirely consistent with the ways in
which the different types of Env protein are produced within the
cell; either these Env proteins are subject to trimerization-im-
posed steric constraints that affect posttranslational modifications
by enzymes (e.g., PDI and mannosidase) or they are not (Fig. 3).
Accordingly, the canonical disulfide-bonding profile and enrich-
ment for high-mannose glycans are interlinked, and arguably de-
fining, properties of a native-like trimer. Whether gp120 mono-
mer subpopulations with canonical and aberrant disulfide bonds
are also differentially glycosylated remains to be determined, but
we suspect that the lack of steric constraints on processing en-
zymes is the dominant factor and that all gp120 proteoforms con-
tain highly processed glycans.
Substantial quantities of aberrant disulfide bonds were identi-
fied in the proteins present in the BG505 SOSIP.664 gp140 mono-
mer and dimer fractions isolated from the SEC columns; these
aberrant bonds are probably present in Env proteins that either
never assembled properly into trimers in the first place or fell apart
early enough to be further processed by PDI. A much smaller
quantity of aberrant disulfide bonds was also detected in the pu-
rified BG505 SOSIP.664 trimer fraction. Here, we think that the
nonnative disulfide bond signals arise from a small proportion
(1 to 4%) of contaminating nonnative forms (e.g., dimers or
aggregates) that are incompletely separated from native-like trim-
ers on SEC columns.
The BG505 SOSIP.664 trimers isolated by the 2G12/SEC puri-
fication method appear almost completely native-like when
viewed by NS-EM (14, 16, 34, 35, 46). BG505 SOSIP.664-His trim-
ers are also fully native-like when purified on Ni-NTA columns via
their C-terminal His tags (14). However, such homogeneity is not
TABLE 3 Aberrant disulfide-linked peptides in Env proteins purified by various methods
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always seen with SOSIP.664 trimers based on other Env geno-
types. Whereas the SOSIP.664-modified BG505, B41, DU422, and
ZM197M env genes have a high potential for yielding native-like
trimers (34, 46, 47), others (e.g., 92UG037.8 and CZA97.012) have
only an intermediate potential (15), and many others have a very
low potential (e.g., multiple env genes listed in reference 47). Thus,
when CZA97.012 and 92UG037.8 SOSIP.664 trimers are purified
by conformationally nonselective methods (lectin, 2G12, or Ni-
NTA columns followed by SEC), only 50% of the trimers are
native-like, while the remainder resemble nonnative uncleaved
gp140 trimers (15). The same finding is broadly true of JR-FL and
16055 SOSIP.664 trimers, prior to negative selection to remove
the nonnative forms (48). We have shown that the nonnative
fraction of CZA97.012 SOSIP.664 trimers is substantially en-
riched for aberrant disulfide bonds, relative to their fully na-
tive-like counterparts (15) We suggest that a similar finding
would be made if the nonnative fractions of 92UG037.8, JR-FL,
and 16055 SOSIP.664 trimers were similarly analyzed. Con-
versely, we hypothesize that, when appropriately purified, the
recently described uncleaved, native-like SC and NFL gp140
proteins, which include a flexible linker to stabilize the gp120 –
gp41 interface together with the SOS and/or I559P changes (12,
48), will mimic SOSIP.664 trimers in being predominantly free
of scrambled disulfide bonds.
The proportion of native-like trimers that arises when SOSIP.664-
modified gp140 proteins are expressed is genotype dependent (15,
47) The underlying reasons are under investigation, but the stability
of the gp120–gp41 interface and/or the trimer apex and the efficiency
with which the intersubunit SOS bond is formed are probably critical
influences on the efficiency of native-like trimer formation. We pro-
pose that whether the native trimer assembles properly or not is,
itself, the critical determinant of the overall disulfide-bonding
profile. Thus, any nonnative gp140 protein in which gp120 has not
stably associated with gp41 will remain vulnerable to disulfide
bond scrambling; conversely, when gp120 interacts properly with
gp41, the resulting native-like trimer is, for steric reasons, resistant
to the effects of any PDI family members it encounters, as shown
in Fig. 3.
The key to producing properly folded Env proteins that are
free of scrambled disulfide bonds therefore lies in the design of
the construct and, often, in the purification strategy used.
BG505 SOSIP.664 trimers and a few other SOSIP.664 trimers
can be purified in fully native form without the use of a bNAb
against a trimer-specific epitope (i.e., the 2G12/SEC method
used here) (34, 46, 47). However, for SOSIP.664 trimers based on
some other genotypes, affinity columns based on quaternary
epitope-specific antibodies, such as PGT145 and PGT151, are
needed in order to positively select for native-like trimer subpopu-
lations (15, 46). The PGT145 or PGT151 positive-selection col-
umns are not useful for nonnative uncleaved gp140 proteins and
gp120 monomers, which predominantly or completely lack these
quaternary epitopes. However, it is possible that any subpopula-
tion of gp120 monomers that is free of scrambled disulfide bonds
could be purified via other antibody affinity columns. Thus, if
there are epitopes, for example, around the CD4-binding site, that
are predominantly or exclusively present only on correctly folded
gp120 monomers (i.e., those with canonical disulfide bonds), the
relevant monoclonal antibodies could be used in positive-selec-
tion columns. A practical limitation would be that if the propor-
tion of gp120 subunits with an aberrant disulfide bond profile is
too high, the losses during purification could be prohibitive from
the yield perspective.
Overall, we conclude that those who design HIV-1 Env pro-
teins for use as vaccine immunogens need to take into account the
presence of aberrantly folded proteins that arise because of disul-
fide bond scrambling during synthesis. The relevant subpopula-
tions can be highly abundant, even predominant. Given the im-
portance of tertiary and often quaternary structure to most Env
epitopes, disulfide bond scrambling will inevitably affect antige-
nicity and may also have a substantial influence on immunogenic-
FIG 3 Protein processing in the ER and Golgi apparatus. The polypeptide chain starts out with no disulfide bonds, and it is homogeneously glycosylated
(precursor glycans). A number of disulfide-bonding configurations are sampled as the Env protein folds, assisted by protein disulfide isomerase (PDI). (A)
Subunits that contain the canonical disulfide-bonding profile can pack into a native-like trimer, and they are then shielded from the actions of PDI (in the ER)
and of glycosidases and glycosyltransferases (in the Golgi apparatus). Accordingly, their glycans remain predominantly in the high-mannose form. (B) In
contrast, nonnative trimers in which the gp120 subunits are not packed properly are not subject to the same steric constraints and hence continue to be
susceptible to PDI activity until they exit the ER. Their disulfide-bonding profile is therefore heterogeneous, with both canonical and aberrant disulfide bonds
present, by the time they exit the ER. In the Golgi apparatus, the glycoforms on these nonnative trimers are trimmed by glycosidases and processed by
glycosyltransferases, such that many of their high-mannose glycans are replaced by more highly processed glycoforms. We propose that monomeric gp120
proteins will be processed in the same way as the gp120 subunits of the nonnative trimers.
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ity. Here, the presence of aberrantly folded subpopulations may
either dilute the responses to the properly folded Env proteins or,
in the worst-case scenario, act as an immunological distraction.
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